Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.15 -0.04 (-3.43%)
As of: Oct 2, 2026 · 10:07 AM EDT

Veraxa Biotech AG - Post de-SPAC (VRXA) Short-term Investments (2024 - 2025)

Updated

Veraxa Biotech AG - Post de-SPAC (VRXA) posted Short-term Investments of $1.39 million for the quarter ended Dec 31, 2025, up 693.1% from $175,345 a year earlier.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Short-term Investments (2024 - 2025) Analysis & Trends

As of Dec 31, 2025, Veraxa Biotech AG - Post de-SPAC's Short-term Investments came in at $1.34 million, up 667.7% from the prior year.

  • In prior years, Veraxa Biotech AG - Post de-SPAC's Short-term Investments was $174,604 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Veraxa Biotech AG - Post de-SPAC 18.09 Mn 14.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.39 Mn
Dec 31, 2024 175,344.60
API Access

Veraxa Biotech AG - Post de-SPAC Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=VRXA&period=max&api_key=YOUR_API_KEY